tradingkey.logo
搜尋

IDEXX Laboratories Inc

IDXX
添加自選
520.050USD
-0.160-0.03%
交易中 09/09, 09:50美東
41.02B總市值
38.00本益比TTM

關於 IDEXX Laboratories Inc 公司

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

IDEXX Laboratories Inc 簡介

公司代碼IDXX
公司名稱IDEXX Laboratories Inc
上市日期Jun 21, 1991
CEOEmerson (Andrew)
員工數量11000
證券類型Ordinary Share
年結日Jun 21
公司地址One Idexx Drive
城市WESTBROOK
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編04092-2041
電話12075560300
網址https://www.idexx.com/
公司代碼IDXX
上市日期Jun 21, 1991
CEOEmerson (Andrew)

IDEXX Laboratories Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Michael G. (Mike) Erickson, Ph.D.
Mr. Michael G. (Mike) Erickson, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
15.00K
+25.25%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Lead Independent Director
Lead Independent Director
8.57K
+3.96%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.43K
+3.05%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager - CAG Diagnostics Business Unit
Executive Vice President and General Manager - CAG Diagnostics Business Unit
8.25K
-3.84%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.89K
+2.86%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
4.34K
+4.13%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.35K
+7.66%
Mr. Michael Schreck
Mr. Michael Schreck
Executive Vice President and General Manager - Veterinary Software, Diagnostic Imaging and Telemedicine, Corporate Accounts and Customer Experience
Executive Vice President and General Manager - Veterinary Software, Diagnostic Imaging and Telemedicine, Corporate Accounts and Customer Experience
3.00K
+36.06%
Mr. Bruce L. Claflin
Mr. Bruce L. Claflin
Independent Director
Independent Director
1.72K
--
Ms. Irene Chang Britt
Ms. Irene Chang Britt
Independent Director
Independent Director
208.00
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Michael G. (Mike) Erickson, Ph.D.
Mr. Michael G. (Mike) Erickson, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
15.00K
+25.25%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Lead Independent Director
Lead Independent Director
8.57K
+3.96%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.43K
+3.05%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager - CAG Diagnostics Business Unit
Executive Vice President and General Manager - CAG Diagnostics Business Unit
8.25K
-3.84%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.89K
+2.86%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
4.34K
+4.13%

常見問題

IDEXX Laboratories Inc的前五大股東是誰?

IDEXX Laboratories Inc的前五大股東如下:Mr. Michael G. (Mike) Erickson, Ph.D.

有多少機構持有IDEXX Laboratories Inc(IDXX)的股份?

截至2026Q1,共有2458家機構持有IDEXX Laboratories Inc的股份,合計持有的股份價值約為76.16M,占公司總股份的96.54% 。與2025Q4相比,機構持股有所增加,增幅為-2089033.00。

哪個業務部門對IDEXX Laboratories Inc的收入貢獻最大?

在2026Q1,CAG Diagnostics recurring revenue業務部門對IDEXX Laboratories Inc的收入貢獻最大,創收974.71M,占總收入的80.12% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有